The Food and Drug Administration (FDA) inspected MicroTransponder, Inc. in Lakeway on March 19, as indicated by data published on the FDA’s website.
Inspectors reviewed the following focus areas:
- Compliance: Devices
- Postmarket Assurance: Devices
The concluding report recommended MicroTransponder, Inc. voluntarily address management operations to resolve identified issues.
Across the United States, the FDA regularly inspects facilities to verify that their environments and products comply with laws and regulations intended to protect public health. The results of these inspections are made publicly available.
The agency’s website states that the FDA is responsible for overseeing the safety and quality of human and animal drugs, biological products, medical supplies, and tobacco products.
Details in this report were sourced from the U.S. Food and Drug Administration. The original data can be accessed here.
